Four years of clinical experience with naproxen--and objective methods of evaluation.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001706:Biopsy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004724:Endoscopy; D005500:Follow-Up Studies; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008738:Methyl Ethers / Q000627:therapeutic use; D009135:Muscular Diseases / Q000188:drug therapy; D009281:Naphthalenes / Q000627:therapeutic use; D010865:Pilot Projects; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013583:Synovial Membrane / Q000473:pathology; D013667:Technetium; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D008738:Methyl Ethers; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates; D013667:Technetium